These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8575441)

  • 1. Protein p53 modulates transcription from a promoter containing its binding site in a concentration-dependent manner.
    Kristjuhan A; Maimets T
    Eur J Biochem; 1995 Dec; 234(3):827-31. PubMed ID: 8575441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.
    Hall SR; Campbell LE; Meek DW
    Nucleic Acids Res; 1996 Mar; 24(6):1119-26. PubMed ID: 8604347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
    Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
    Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of transcription and interference with DNA binding of TATA-binding protein by C-terminal alternatively spliced p53.
    Huang H; Kaku S; Knights C; Park B; Clifford J; Kulesz-Martin M
    Exp Cell Res; 2002 Oct; 279(2):248-59. PubMed ID: 12243750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.
    Shin TH; Paterson AJ; Kudlow JE
    Mol Cell Biol; 1995 Sep; 15(9):4694-701. PubMed ID: 7651386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
    Lohrum M; Scheidtmann KH
    Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression by p53 through direct binding to a novel DNA element.
    Johnson RA; Ince TA; Scotto KW
    J Biol Chem; 2001 Jul; 276(29):27716-20. PubMed ID: 11350951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis.
    Zhang N; Jiang T; Wang Y; Wang S; Hu L; Bu Y
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32093041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation.
    Preuss U; Kreutzfeld R; Scheidtmann KH
    Int J Cancer; 2000 Oct; 88(2):162-71. PubMed ID: 11004663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
    Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
    J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
    Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
    Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
    Pesch J; Brehm U; Staib C; Grummt F
    J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
    Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
    Shan B; Morris GF
    Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.